Machine Learning for Early Diagnosis of Endometriosis(MLEndo)

NCT ID: NCT06147687

Last Updated: 2023-11-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

10000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-01-01

Study Completion Date

2024-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The project aims to create a large prospective data bank using the Lucy medical mobile application and collect and analyze patient profiles and structured clinical data with artificial intelligence. In addition, authors will investigate the association of removed or restricted dietary components with quality of life, pain, and central sensitization.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Introduction: Endometriosis is a complex and chronic disease that affects ∼176 million women of reproductive age and remains largely unresolved. It is defined by the presence of endometrium-like tissue outside the uterus and is commonly associated with chronic pelvic pain, infertility, and decreased quality of life. Despite numerous proposed screening and triage methods such as biomarkers, genomic analysis, imaging techniques, and questionnaires to replace invasive diagnostic laparoscopy, none have been widely adopted in clinical practice.

. Despite the availability of various screening methods (e.g., biomarkers, genomic analysis, imaging techniques) that are intended to replace the need for invasive diagnostic laparoscopy, the time to diagnosis remains in the range of 4 to 11 years. Aims: The project aims to create a large prospective data bank using the Lucy medical mobile application and collect and analyze patient profiles and structured clinical data with artificial intelligence. In addition, authors will investigate the association of removed or restricted dietary components with quality of life, pain, and central sensitization. Methods: A Baseline and Longitudinal Questionnaire in the Lucy app collects self-reported information on symptoms related to endometriosis, socio-demographics, mental and physical health, nutritional, and other lifestyle factors. 5,000 women with endometriosis and 5,000 women in a control group will be enrolled and followed up for one year. With this information, any connections between symptoms and endometriosis will be analyzed with machine learning. Conclusions: Authors can develop a phenotypic description of women with endometriosis by linking the collected data with existing registry-based information on endometriosis diagnosis, healthcare utilization, and big data approach. This may help to achieve earlier detection of endometriosis with pelvic pain and significantly reduce the current diagnostic delay. Additionally, authors can identify nutritional components that may worsen the quality of life and pain in women with endometriosis; thus, authors can create evidence-based dietary recommendations.

Keywords: Endometriosis, Machine learning, Non-invasive diagnosis, Diet

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Endometriosis Pelvic Pain Infertility, Female

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients with endometriosis and Healthy controls

5 000 people with endometriosis will be enrolled and followed up for 1one year. To participate in the study, the women must meet the inclusion criteria.

Self reported data collection

Intervention Type DIAGNOSTIC_TEST

ML assessement of colleceted data

Control

5 000 people in a control group will be enrolled and followed up for 1one year. To participate in the study, the women must meet the inclusion criteria.

Self reported data collection

Intervention Type DIAGNOSTIC_TEST

ML assessement of colleceted data

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Self reported data collection

ML assessement of colleceted data

Intervention Type DIAGNOSTIC_TEST

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

ML assessement

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Women in reproductive age
* 5000 patients with endometriosis
* 5000 patients without endometriosis

Exclusion Criteria

* Ongoing pregnancy
* Malignant condition of ovary/uterus/breast
Minimum Eligible Age

14 Years

Maximum Eligible Age

45 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Aarhus

OTHER

Sponsor Role collaborator

Semmelweis University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Attila Bokor

Role: PRINCIPAL_INVESTIGATOR

Semmelweis University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Bokor Attila

Budapest, , Hungary

Site Status RECRUITING

Semmelweis University

Budapest, , Hungary

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Hungary

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Attila Bokor

Role: CONTACT

703118868 ext. 0036

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Bokor Attila

Role: primary

06703118868

Attila Bokor, MD, PhD

Role: primary

+36703118868

Dora Balogh, PhD

Role: backup

+3604591500 ext. Bokor

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Semmelweis

Identifier Type: -

Identifier Source: org_study_id